SHIM
CLBT icon

Stone House Investment Management’s Cellebrite CLBT Stock Holding History

Stone House Investment Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.4K Buy
96
+60
+167% +$793 ﹤0.01% 809
2026
Q1 		$496 Buy
+36
New +$543 ﹤0.01% 817

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Stone House Investment Management's CLBT Position: Q2 2026 in Review

Stone House Investment Management increased its Cellebrite (CLBT) stake by 167% in Q2 2026, buying an estimated $793 and bringing the position to 96 shares worth $1.4K. The position accounts for ﹤0.01% of the portfolio, ranked #809.

Stone House Investment Management first reported a position in CLBT in Q1 2026 and has held it in 2 quarters since. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Stone House Investment Management held 96 shares of Cellebrite worth $1.4K as of Q2 2026.
  • Stone House Investment Management bought 60 Cellebrite shares in Q2 2026, an estimated $793.
  • Cellebrite made up ﹤0.01% of Stone House Investment Management's portfolio in Q2 2026, its #809 holding.
  • Stone House Investment Management first reported a position in Cellebrite in Q1 2026 and has held it in 2 quarters since.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Stone House Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.